Literature DB >> 20401599

[Lipid storage myopathies. A clinical and pathobiochemical challenge].

T Skuban1, T Klopstock, B Schoser.   

Abstract

Lipid storage myopathies are a clinically and genetically heterogeneous group of muscle diseases characterized by an accumulation of lipid in skeletal muscle. Currently four different groups of lipid storage myopathies are described: primary carnitine deficiency (PCD), multiple acyl-CoA dehydrogenase deficiency, primary and secondary coenzyme Q10 deficiency and neutral lipid storage diseases. It might be due to their rareness and considerable clinical variability that these disorders are frequently disregarded in neurological differential diagnosis. This article provides a synopsis of several new aspects of pathophysiology, symptoms, diagnostic tools and current therapeutic approaches of lipid storage myopathies.

Entities:  

Mesh:

Year:  2010        PMID: 20401599     DOI: 10.1007/s00115-010-3009-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  40 in total

Review 1.  Clinical trials of coenzyme Q10 in neurological disorders.

Authors:  Clifford W Shults; Richard Haas
Journal:  Biofactors       Date:  2005       Impact factor: 6.113

2.  Triglyceride deposit cardiomyovasculopathy.

Authors:  Ken-ichi Hirano; Yoshihiko Ikeda; Nobuhiro Zaima; Yasuhiko Sakata; Goro Matsumiya
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

3.  Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome.

Authors:  C Lefèvre; F Jobard; F Caux; B Bouadjar; A Karaduman; R Heilig; H Lakhdar; A Wollenberg; J L Verret; J Weissenbach; M Ozgüc; M Lathrop; J F Prud'homme; J Fischer
Journal:  Am J Hum Genet       Date:  2001-10-02       Impact factor: 11.025

4.  Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome.

Authors:  Achim Lass; Robert Zimmermann; Guenter Haemmerle; Monika Riederer; Gabriele Schoiswohl; Martina Schweiger; Petra Kienesberger; Juliane G Strauss; Gregor Gorkiewicz; Rudolf Zechner
Journal:  Cell Metab       Date:  2006-05       Impact factor: 27.287

Review 5.  CoQ10 deficiency diseases in adults.

Authors:  Catarina M Quinzii; Michio Hirano; Salvatore DiMauro
Journal:  Mitochondrion       Date:  2007-03-27       Impact factor: 4.160

6.  Clinical and genetic characterization of Chanarin-Dorfman syndrome.

Authors:  Claudio Bruno; Enrico Bertini; Maja Di Rocco; Denise Cassandrini; Giuseppe Ruffa; Teresa De Toni; Marco Seri; Marco Spada; Giovanni Li Volti; Adele D'Amico; Federica Trucco; Marcello Arca; Carlo Casali; Corrado Angelini; Salvatore Dimauro; Carlo Minetti
Journal:  Biochem Biophys Res Commun       Date:  2008-03-11       Impact factor: 3.575

7.  Clinical and genetic analysis of lipid storage myopathies.

Authors:  Aya Ohkuma; Satoru Noguchi; Hideo Sugie; May Christine V Malicdan; Tokiko Fukuda; Kunio Shimazu; Luis Carlos López; Michio Hirano; Yukiko K Hayashi; Ikuya Nonaka; Ichizo Nishino
Journal:  Muscle Nerve       Date:  2009-03       Impact factor: 3.217

8.  ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.

Authors:  Rikke K J Olsen; Simon E Olpin; Brage S Andresen; Zofia H Miedzybrodzka; Morteza Pourfarzam; Begoña Merinero; Frank E Frerman; Michael W Beresford; John C S Dean; Nanna Cornelius; Oluf Andersen; Anders Oldfors; Elisabeth Holme; Niels Gregersen; Douglass M Turnbull; Andrew A M Morris
Journal:  Brain       Date:  2007-06-20       Impact factor: 13.501

9.  Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency.

Authors:  S Di Giovanni; M Mirabella; A Spinazzola; P Crociani; G Silvestri; A Broccolini; P Tonali; S Di Mauro; S Servidei
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

Review 10.  Human coenzyme Q10 deficiency.

Authors:  Catarina M Quinzii; Salvatore DiMauro; Michio Hirano
Journal:  Neurochem Res       Date:  2006-11-10       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.